#biotech search results

CMPX: tovecimig+paclitaxel hits PFS/ORR in biliary cancer. Crossover survival boost strengthens FDA case. Stock down 60%+ in a month; positive data may spark short squeeze. Short-term bullish above 1.61. Risk: FDA path uncertain. #CMPX #Biotech #NASDAQ

pharmadevicenews.com/why-biovie-inc… #ParkinsonsDisease #Neurodegeneration #Biotech #ClinicalTrials #DrugDevelopment #Neuroinflammation #PharmaNews #Biotechnology #CNSResearch

AI can design and run thousands of lab experiments without human hands. Humanity isn’t ready for the new risks this brings to biology - The Conversation theconversation.com/ai-can-design-… #biotech #geneediting #genomeengineering #lifesciences #drugdevelopment #biomedical

BEC Search continues its partnership with #AgiosPharmaceuticals - an organization deeply committed to patients first and to advancing science that transforms lives. We are Hiring! #LifeSciences #Biotech #SickleCellDisease #Hiring #Recruiting #Pharmaceuticals #RareDisease

$KALA #biotech #groundbreaking Historic U.S. Executive Order Fast-Tracks Psychedelic Research Access; Landmark Policy Shift Strengthens the Outlook for KALA’s Client Red Light Holland and Positions Researgency.ai as the Dedicated AI Infrastructure Partner for the Global

Boston’s first-ever 𝐓𝐞𝐜𝐡 𝐖𝐞𝐞𝐤 is here—and 𝐍𝐮𝐜𝐥𝐞𝐚𝐭𝐞 𝐱 𝐑𝐡𝐨 are building the home base for biotech founders at our Innovation HQ (745 Atlantic). Spots are limited; RSVP 𝐭𝐨𝐝𝐚𝐲! loom.ly/NSuTjso loom.ly/EoKpLXc #biotech #Boston #techweek

Scientists have cracked a major hurdle in organ banking: by fine-tuning the temp to enter a glass-like state, they can freeze organs without cracking. This could bring lab-grown, banked organs closer to reality. #Biotech #Cryonics #TransplantScience ift.tt/PCwou1W

#funny #biotech #genetics #biology #lab #chromosomes #mitosis #CatsLovers

The network is expanding with founders working across science, scale, and supply chains. If you’re building in #agrifoodtech, #climatetech, #biotech, #sustainablematerials or #sustainableAI, join the platform 👇🏽 vevolution.com/register

Generating data is cheap. Making it talk to each other is the actual battle. 🧬⚔️ Genyx LLC bridges the gap between proteomics and genomics to turn siloed data into unified discovery. Book a consult 👉 genyxllc.com #MultiOmics #Biotech #Genomics #Genyx #AI

Recombinant antibodies are increasingly used for more consistent results in research labs 🧬 ✨ 30 mL expression — $239 ✔ Gene → purified antibody ✔ Guaranteed quantity ✔ No charge if yield < 1 mg 👉hubs.la/Q04dw93-0 #biotech #antibodies #proteinexpression

UK leads European biotech investment, BIA reports ddw-online.com/uk-leads-europ… Follow DDW; Business insights for the global scientific community #Biotech

🚨 $CVM ON HIGH ALERT 🚨 CEL-SCI is lining up a major biotech catalyst: Multikine confirmatory registration study expected to start enrollment summer 2026. Small-cap cancer immunotherapy story back on watch. 👀🔥 youtube.com/watch?v=MZQt_B… #CVM #Biotech #CancerStocks #SmallCaps

SYMBIO NEXUS is LIVE! 🚀 Today, we are beyond excited to announce the launch of SYMBIO NEXUS, the computational biology partner every modern life scientist deserves. Let’s connect the dots between data and discovery 🌐 symbionexuslabs.com #SYMBIO_NEXUS #BioTech #Startup

Eli Lilly is acquiring Ajax Therapeutics for up to $2.3B as part of a rapid series of oncology deals. The deal focuses on an early-stage blood cancer drug targeting JAK2. biospace.com/deals/lilly-la… #lilly #oncology #biotech #mergersandacquisitions #drugdevelopment

📊 $MANE +41% | Post-Open Alert ⚠️ SQUEEZE RISK: 55% Float: 28.8M Short Float: 6.23% MCap: $3.57B Catalyst: Phase 2/3 hair loss trial shows strong efficacy, no CV events Real catalyst, bigger cap = momentum play, not squeeze trap. #MANE #Biotech

📊 $SGMT +41% | Post-Open Alert ⚠️ SQUEEZE RISK: 65% Float: 27.1M Short Float: 13.27% 🔴 Short Ratio: 7.02 days 🔴 Catalyst: $175M offering at $6 for Phase 3 acne trial High short ratio + dilution priced in. Watch for short covering rally. #SGMT #Biotech

BD and Suttons Creek Partner to Help Pharma and Biotech Companies Deliver Combination Products to Market with Confidence. Collaboration to help pharma and biotech companies reduce risk and navigate complexity for combination products... biotechnewswire.ai/202604272779/b… #biotech #medtech

Tumor organoids could transform cancer treatment by making it more personalized, faster, and more effective for each patient. #Healthcare #Biotech #CancerTreatment #Science #NextGenMedicine @SenduraiMani

Breakthrough science gets you noticed. It doesn’t get you scaled. At some point, the constraint shifts from discovery… to leadership, structure, and execution. That’s where many companies stall. bit.ly/4co5pfH #Leadership #LifeSciences #Biotech

Oral Alzheimer’s pipeline advances as biotech pushes for scalable, disease-modifying treatments beyond infusions. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #innovation

$IBB #biotech back to major resistance line

Cambridge-based @STORMTherapeutics, a #BioTech company targeting #RNA modifications to reprogram cells and develop novel #cancer therapies, today announced that it has secured €47.5 million in Series C financing. 🇬🇧 🧬💉 eu-startups.com/2026/04/storm-…

ecanemab enters its next phase as real-world data begins to shape how Alzheimer’s treatment works beyond clinical trials. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #innovation

Parkinson’s drug shows unexpected effects, highlighting how targeting complex brain pathways can backfire in clinical development. ㅤ Link in bio. ㅤ #longevity #parkinsons #biotech #healthspan #innovation

FDA fast-tracks a bioengineered liver technology, accelerating efforts to address organ shortages with regenerative solutions. ㅤ Link in bio. ㅤ #longevity #biotech #healthspan #innovation #regenerativemedicine

Alzheimer’s drug clears Phase 2a with early signals it may be targeting neuroinflammation—not just symptoms. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #brainhealth

Neurons over silicon: Singapore plans first biological #datacentre buff.ly/RXkaiuZ v/ @computerweekly #AI #Biotech Cc @jblefevre60 @ahier @TamaraMcCleary @Nicochan33 @Fabriziobustama

Parkinson’s drug cuts “off” time in Phase 2, pointing to new approaches beyond dopamine for more consistent symptom control. ㅤ Link in bio. ㅤ #longevity #parkinsons #biotech #healthspan #innovation

Biotech moves mitochondria into the clinic as longevity shifts from theory to human intervention. ㅤ Link in bio. ㅤ #longevity #biotech #healthspan #innovation #mitochondria

Getting #MoffittBOB started @MoffittNews with an economic development breakfast, welcoming key leaders for a chat about the future of #biotech in our region. Thanks to Tim Plett, Executive Director, Life Sciences and Commercial Banking @jpmorgan for a great presentation.

All in all, it was a strong first quarter for the #biotech sector, marked by a high level of M&A activity that is set to continue. I’d like to wish you and your families a happy Easter. I hope you enjoy my posts and ideas! 🙏 $XBI $TERN $DAWN $APLS $VTYX $CNTA $ACLX

If you're a professional in #ICT, #biotech or #cleantech, Valais is hiring! Join the #WorkinginValais event on 23 April from 10:00 to 12:30 CET to: 💼 Browse open vacancies 🤝 Chat with employers 📝 Learn about working in Valais Register 👉 europeanjobdays.eu/en/event/work-… #EURESJobs

RNA editing enters the clinic as AIRNA doses its first patient, advancing a new class of therapies that repair genetic mutations without altering DNA. ㅤ Link in bio. ㅤ #longevity #biotech #rna #healthspan #innovation

Great to have @BioFlorida at @MoffittNews today for a roundtable on strengthening Florida’s #biotech ecosystem and advancing innovation to drive impact for patients. @DrJamesMule @ProfGregSawyer @wjameswilson

$IOVA Institutional Analysis: Latest SEC filings confirm aggressive accumulation by major funds like BlackRock and State Street. Institutional ownership hits 63.68%, with a consensus price target of $9.00 (Yahoo/Finviz). Strong market confidence. #IOVA #Biotech #Investing

🚨 $IOVA scaling up! New job postings confirm 24/7 operations with Night Shifts (A & B) for Aseptic Manufacturing in Philly. If they’re producing til dawn, demand for AMTAGVI is surging. Clear bullish signal on scalability and patient uptake. 🚀 #IOVA #Biotech #StockMarket

Soranlar var; ‘hep aynı hisseler mi?’ diye. Hiç olur mu! Kimseden duymacağınız hisseler @TradersPub ‘ta. #borsa #biotech

#1AD $10M MC💥 #Cancer #Biotech NEWS ⏩#1AD,ORIBIOTECH & CELL THERAPIES SIGN MOU⏪ 💥MOU to bring Oribiotech’s automated #celltherapy manufacturing platform, IRO, to Australia & Asia Pacific region 💥IRO aims to address key CAR-T challenges: High cost Slow production

BD and Suttons Creek Partner to Help Pharma and Biotech Companies Deliver Combination Products to Market with Confidence. Collaboration to help pharma and biotech companies reduce risk and navigate complexity for combination products... biotechnewswire.ai/202604272779/b… #biotech #medtech